Solid Biosciences Inc.

General ticker "SLDB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $240.4M (TTM average)

Solid Biosciences Inc. does not follow the US Stock Market performance with the rate: -7.0%.

Estimated limits based on current volatility of 12.0%: low 2.52$, high 3.21$

Factors to consider:

  • Earnings expected soon, date: 2025-05-21 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.43$, 7.04$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.23$, 3.89$]

Financial Metrics affecting the SLDB estimates:

  • Negative: Non-GAAP EPS, $ of -2.93 <= 0.04
  • Negative: Operating cash flow per share per price, % of -33.53 <= 1.79
  • Negative: negative Net income
  • Positive: Shareholder equity ratio, % of 72.75 > 63.75
  • Negative: negative Operating income
  • Positive: -0.87 < Investing cash flow per share, $ of -0.39
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: negative Industry operating income (median)
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82

Similar symbols

Short-term SLDB quotes

2025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-092025-05-122.533.54
Price $

Long-term SLDB plot with estimates

2468101214Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.8−0.6−0.4−0.20
SLDBS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $8.09MM $0.00MM $0.00MM
Operating Expenses $114.55MM $104.25MM $129.73MM
Operating Income $-106.45MM $-104.25MM $-129.73MM
Non-Operating Income $20.47MM $8.24MM $5.03MM
Interest Expense $0.00MM $0.44MM $0.34MM
R&D Expense $78.42MM $76.56MM $96.43MM
Income(Loss) $-85.98MM $-96.02MM $-124.70MM
Profit(Loss)* $-65.51MM $-96.02MM $-124.70MM
Stockholders Equity $211.67MM $126.48MM $137.25MM
Assets $260.25MM $164.94MM $188.66MM
Operating Cash Flow $-97.98MM $-94.18MM $-100.01MM
Capital expenditure $3.02MM $1.51MM $0.65MM
Investing Cash Flow $59.16MM $9.69MM $-16.09MM
Financing Cash Flow $74.83MM $3.12MM $122.44MM
Earnings Per Share** $-7.70 $-4.83 $-3.06

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.